Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Spinocerebellar Ataxia Type 7
NCT03660917Phase 3Recruiting
- Sponsor
- Sant'Andrea Hospital
- Start
- Jun 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riluzole in spinocerebellar ataxia type 7 (SCA7), sponsored by Sant'Andrea Hospital. Started Jun 2021; status: recruiting.
02
Drugs
riluzole
03
Conditions
spinocerebellar ataxia type 7 (SCA7)
Beyond the preview
Go deeper on NCT03660917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660917.